Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: A potential marker for response?

详细信息	查看全文 | 推荐本文 |

• 作者：Charles R. Conway^a ; ^b ; ^{cconway@wustl.edu} ; John T. Chibnall^b ; Sunil Gangwani^a ; Mark A. Mintun^a ; ^c ; ^d ; Joseph L. Price^e ; Tamara Hershey^a ; ^c ; ^f ; Luis A. Giuffra^a ; Richard D. Bucholz^g ; Jon J. Christensen^c ; Yvette I. Sheline^a ; ^c ; ^f
• 关键词：Vagus nerve stimulation ; Depression ; Positron emission tomography ; Treatment-resistant depression ; Fluorodeoxyglucose PET ; Treatment response
• 刊名：Journal of Affective Disorders
• 出版年：2012
• 期刊代码：141_01650327
• 类别：med
• 出版时间：August, 2012
• 卷：139
• 期：3
• 页码：283-290
• 文件大小：344 K

摘要

Background

Pretreatment brain activity in major depressive disorder correlates with response to antidepressant therapies, including pharmacotherapies and transcranial magnetic stimulation. The purpose of this trial was to examine whether pretreatment regional metabolic activity in selected regions of interest (ROIs) predicts antidepressant response following 12 months of vagus nerve stimulation (VNS) in 15 patients with treatment-resistant major depression (TRMD).

Methods

Fluorodeoxyglucose positron emission tomography (FDG PET) was used to assess regional mean relative cerebral metabolic rate for glucose (CMRGlu) in four ROIs (anterior insular, orbitofrontal, anterior cingulate, and dorsolateral prefrontal cortices) at baseline (prior to VNS activation). Depression severity was assessed at baseline and after 12 months of VNS using the Hamilton Depression Rating Scale (HDRS), with response defined as 鈮?#xA0;50%reduction in HDRS from baseline.

Results

Baseline CMRGlu in the anterior insular cortex differentiated VNS responders (n = 11) from nonresponders (n = 4) and correlated with HDRS change (r = .64, p = .01). In a regression analysis, lower anterior insular cortex CMRGlu (p = .004) and higher orbitofrontal cortex CMRGlu (p = .047) together predicted HDRS change (R² = .58, p = .005). In a whole brain, voxel-wise analysis, baseline CMRGlu in the right anterior insular cortex correlated with HDRS change (r = .78, p = .001).

Limitations

Sample size was small, limiting statistical power; patients remained on their psychiatric medications; study was open-label and uncontrolled.

Conclusions

This preliminary study suggests that pretreatment regional CMRGlu may be useful in predicting response to VNS in TRMD patients.